
Market Overview
Peptic ulcers, also known as stomach or intestinal ulcers, are sores or lesions that develop on the inner lining of the stomach or small intestine. Peptic ulcers can be caused by an excess of acid in the stomach, infection with Helicobacter pylori bacteria and long-term usage of nonsteroidal anti-inflammatory drugs like aspirin and ibuprofen. The key types of drugs used in treatment of peptic ulcers are proton pump inhibitors, H2 blockers, antibiotics and gastric mucosal protective drugs. Proton pump inhibitors are considered most effective treatment option as they reduce acid production in the stomach. Increased consumption of proton pump inhibitors and H2 blockers for management of ulcers and rising cases of peptic ulcers are driving the growth of global peptic ulcer drugs market.
The Global Peptic Ulcer Drugs market demand is estimated to be valued at US$ 34.34 Billion in 2023 and is expected to exhibit a CAGR of 4.1% during the forecast period (2023-2030).
Key Takeaways
Key players operating in the peptic ulcer drugs market are Daewoong, Takeda Pharmaceuticals, Abbott laboratories, AstraZeneca and Eisai Co. Ltd. Some key opportunities in the market include increase in awareness regarding treatment options and rising healthcare expenditure in developing nations. Also, various companies are engaged in R&D for development of novel drugs with lower side effects. Globally, the market leaders are expanding their geographical footprint by entering emerging markets of Asia Pacific, Latin America, Africa and Middle East through partnerships and acquisitions. For instance, in 2019, Takeda Pharmaceuticals acquired Shire to strengthen its position in core therapeutic areas including gastroenterology.
Market Drivers
Rising prevalence of Peptic Ulcer Drugs Market Demand is estimated that around 4 million Americans are diagnosed with peptic ulcers each year. Changing lifestyle, alcohol consumption and smoking habits are contributing to increased cases of ulcers.
Market Restrains Side effects associated with long term usage of anti-ulcer drugs such as diarrhea, headache and drug interactions can negatively impact the market growth. Also, availability of alternative treatment therapies such as antibiotics, surgery and lifestyle modifications pose a challenge for anti-ulcer drugs market.
Segment Analysis Peptic Ulcer Drugs market can be segmented on the basis of drug class and route of administration. Based on drug class, the market is segmented into proton pump inhibitors, H2-blockers, antacids and others. Proton pump inhibitors dominates the market as they are more effective than H2-blockers in treating ulcers and provides long term ulcer healing. Proton pump inhibitors works by reducing the amount of acid produced in the stomach. Based on route of administration, the market is segmented into oral andn injectable. Oral drugs dominates the segment as they are convenient to administer and shows better patient compliance compared to injectable drugs due to non-invasive nature.
Global Analysis
Regionally, North America dominates the Peptic Ulcer Drugs market due to rising geriatric population suffering from acid peptic disorders and growing adoption of proton pump inhibitors drugs in the region. Europe represents the second largest market due to increasing technological advancements in drug development. However, Asia Pacific is anticipated to witness fastest growth rate over the forecast period majorly due to increasing penetration of major pharmaceutical companies in developing countries such as India and China and rising healthcare spending. Rising ageing population and growing awareness regarding disease management are factors expected to propel the regional growth. Key players focus on emerging markets for business expansion by adopting strategies including new product launches and collaborations.
Get More Insights On- Peptic Ulcer Drugs Market
Get This Report In Japanese-
Get This Report In Korean-
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
( https://www.linkedin.com/in/ravina-pandya-1a3984191 )